Study of VX-985 in Subjects With Chronic Hepatitis C
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study it to evaluate the safety and tolerability of VX-985 in HCV
subjects. This study will also evaluate the antiviral activity and pharmacokinetic profile of
VX-985.